Core Laboratories N.V. (NYSE:CLB) has earned a consensus rating of “Hold” from the seventeen brokerages that are covering the company, MarketBeat Ratings reports. Four research analysts have rated the stock with a sell rating, eight have given a hold rating and five have issued a buy rating on the company. The average 1 year price target among analysts that have covered the stock in the last year is $113.36.

A number of research analysts recently issued reports on CLB shares. ValuEngine cut Core Laboratories N.V. from a “hold” rating to a “sell” rating in a research note on Friday, September 1st. Royal Bank Of Canada cut their price target on Core Laboratories N.V. from $115.00 to $112.00 and set an “outperform” rating on the stock in a research note on Thursday, September 7th. Credit Suisse Group upgraded Core Laboratories N.V. from a “neutral” rating to an “outperform” rating and set a $110.00 price target on the stock in a research note on Thursday, August 24th. They noted that the move was a valuation call. Cowen and Company restated a “hold” rating and issued a $100.00 price target on shares of Core Laboratories N.V. in a research note on Friday, September 1st. Finally, BidaskClub upgraded Core Laboratories N.V. from a “sell” rating to a “hold” rating in a research note on Wednesday, July 5th.

COPYRIGHT VIOLATION WARNING: This article was originally posted by American Banking News and is owned by of American Banking News. If you are viewing this article on another publication, it was copied illegally and republished in violation of United States and international copyright legislation. The original version of this article can be read at https://www.americanbankingnews.com/2017/10/04/core-laboratories-n-v-clb-given-average-rating-of-hold-by-brokerages.html.

A number of institutional investors and hedge funds have recently made changes to their positions in the business. Stephens Inc. AR boosted its stake in shares of Core Laboratories N.V. by 1.0% during the 1st quarter. Stephens Inc. AR now owns 3,046 shares of the oil and gas company’s stock worth $352,000 after acquiring an additional 31 shares in the last quarter. Callahan Advisors LLC boosted its stake in shares of Core Laboratories N.V. by 2.5% during the 2nd quarter. Callahan Advisors LLC now owns 2,075 shares of the oil and gas company’s stock worth $210,000 after acquiring an additional 50 shares in the last quarter. Janus Henderson Group PLC boosted its stake in shares of Core Laboratories N.V. by 1.3% during the 2nd quarter. Janus Henderson Group PLC now owns 5,002 shares of the oil and gas company’s stock worth $506,000 after acquiring an additional 64 shares in the last quarter. Laurel Wealth Advisors Inc. boosted its stake in shares of Core Laboratories N.V. by 3.2% during the 1st quarter. Laurel Wealth Advisors Inc. now owns 2,071 shares of the oil and gas company’s stock worth $239,000 after acquiring an additional 65 shares in the last quarter. Finally, First Bank & Trust boosted its stake in shares of Core Laboratories N.V. by 5.8% during the 2nd quarter. First Bank & Trust now owns 1,493 shares of the oil and gas company’s stock worth $152,000 after acquiring an additional 82 shares in the last quarter.

Shares of Core Laboratories N.V. (NYSE:CLB) traded down 1.52% during midday trading on Wednesday, reaching $96.05. The company had a trading volume of 405,645 shares. The company has a 50 day moving average of $93.23 and a 200 day moving average of $102.92. Core Laboratories N.V. has a 12-month low of $86.55 and a 12-month high of $125.83. The firm has a market capitalization of $4.24 billion, a price-to-earnings ratio of 58.93 and a beta of 1.63.

Core Laboratories N.V. (NYSE:CLB) last released its quarterly earnings results on Monday, July 24th. The oil and gas company reported $0.52 EPS for the quarter, topping the consensus estimate of $0.51 by $0.01. Core Laboratories N.V. had a return on equity of 49.29% and a net margin of 11.80%. The business had revenue of $163.90 million during the quarter, compared to analyst estimates of $168.23 million. During the same period last year, the business posted $0.35 earnings per share. The company’s quarterly revenue was up 10.7% on a year-over-year basis. Analysts anticipate that Core Laboratories N.V. will post $1.99 EPS for the current year.

About Core Laboratories N.V.

Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples.

Analyst Recommendations for Core Laboratories N.V. (NYSE:CLB)

Receive News & Ratings for Core Laboratories N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories N.V. and related companies with MarketBeat.com's FREE daily email newsletter.